Richman Michael 4
4 · NextCure, Inc. · Filed Mar 16, 2021
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Richman Michael
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-03-15+300,000→ 300,000 totalExercise: $12.59Exp: 2031-03-14→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on March 15, 2022. The remainder vests in 36 monthly installments beginning on April 15, 2022.